Synektik

Synektik EBITDA per Employee

The EBITDA per Employee of Synektik (SNT.WA) as of Oct 31, 2026 is 1.08 M PLN. In the previous year, EBITDA per Employee was 737,536.07 PLN — a change of 46.83% (higher).

EBITDA per Employee

1.08 MPLN

YoY

46.83%

Last updated:

EBITDA per Employee of Synektik is 2025 1.08 M PLN. EBITDA per Employee of Synektik was 2024 737,536.07 PLN. It decreases by 46.83% higher compared to the previous year.

The Synektik EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2018
80,214.95 PLN
Jan 1, 2019
87,690.23 PLN
Jan 1, 2020
82,975.34 PLN
Jan 1, 2021
77,152.95 PLN
Jan 1, 2022
48,543.87 PLN
Jan 1, 2023
468,016.00 PLN
Jan 1, 2024
737,536.07 PLN
Jan 1, 2025
1.08 M PLN
The Synektik EBITDA per Employee history
YEAREBITDA per EmployeeYoY
1.08 MPLN+46.83%
737,536.07PLN+57.59%
468,016.00PLN+864.11%
48,543.87PLN-37.08%
77,152.95PLN-7.02%
82,975.34PLN-5.38%
87,690.23PLN+9.32%
80,214.95PLN+225.39%
24,652.14PLN+67.97%
14,676.38PLN-473.86%
-3,925.68PLN-110.54%
37,238.86PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Synektik Stock analysis

What does Synektik do? Synektik SA generates revenue through its PACS software, which enables diagnostic imaging laboratories to operate efficiently. The company also sells medical equipment and provides services through its imaging equipment services center. Synektik SA partners with Siemens and holds a 100% stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o, which it acquired by raising its stake on November 28, 2013. The firm's research laboratory conducts acceptance and specialist tests on X-ray equipment, contributing to its service offerings. The primary buyers of Synektik SA's products include diagnostic imaging laboratories that require PACS software for their operations. Medical equipment is sold to healthcare facilities, while the research laboratory services are utilized by entities needing X-ray equipment testing. The company's partnership with Siemens supports its medical equipment sales and services. Synektik SA's revenue streams are derived from software licensing, medical equipment sales, and specialized testing services. The company's focus on diagnostic imaging solutions and its ownership of Miedzynarodowe Centra Medyczne Inwestycje Sp z o o position it within the medical technology sector, targeting healthcare providers and imaging laboratories. Synektik is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Synektik stock

EBITDA per Employee of Synektik is 1.08 M PLN in 2025.

EBITDA per Employee of Synektik changed from 737,536.07 PLN to 1.08 M PLN, representing a 46.83% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Synektik since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Synektik historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — Synektik

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Synektik